Further Evidence of Varying Risks and Benefits of Different Inhaled Corticosteroid/Long-acting Beta-agonist Combinations in COPD.

Suppr

超能文献

作者信息

Tashkin Donald P

机构信息

Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.

出版信息

Chest. 2020 May;157(5):1067-1069. doi: 10.1016/j.chest.2020.01.009.

DOI:10.1016/j.chest.2020.01.009

PMID:32386630

Abstract

摘要

相似文献

Further Evidence of Varying Risks and Benefits of Different Inhaled Corticosteroid/Long-acting Beta-agonist Combinations in COPD.

Chest. 2020 May;157(5):1067-1069. doi: 10.1016/j.chest.2020.01.009.

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.

Long-Acting β-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1641-1644. doi: 10.1164/rccm.201710-2052LE.

Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2007 Oct 17(4):CD006829. doi: 10.1002/14651858.CD006829.

Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.

Prescrire Int. 2016 Nov;25(176):272-277.

Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?

Curr Opin Pulm Med. 2005 Mar;11(2):121-8. doi: 10.1097/00063198-200503000-00004.

Switching from long-acting beta-agonist and inhaled corticosteroid to long-acting beta-agonist and long-acting muscarinic antagonist for chronic obstructive pulmonary disease: a case report of inhaled corticosteroid withdrawal.

Intern Med J. 2020 Sep;50 Suppl 3:15-18. doi: 10.1111/imj.14931.

Inappropriate inhaled corticosteroid prescribing in chronic obstructive pulmonary disease patients.

Intern Med J. 2017 Nov;47(11):1310-1313. doi: 10.1111/imj.13611.

Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 17;11:1921-8. doi: 10.2147/COPD.S109661. eCollection 2016.

Comparative Effectiveness of Long-Acting Beta -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.

Pharmacotherapy. 2017 Apr;37(4):447-455. doi: 10.1002/phar.1913.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验